Iovance Biotherapeutics Investor Presentation
Iovance Biotherapeutics updated its corporate presentation for use at upcoming healthcare conferences and meetings with analysts and stockholders. The November 2026 presentation provides a corporate overview and updates on the company's cell therapy pipeline and commercialization efforts.